ProAlt is a biotechnological company offering different products and services related to protein/antibodies design, development, and manufacturing. Their main focus is on the development and commercialization of biomarker-based assays for early cancer diagnosis and clinical disease management. They also offer their own manufactured innovative protein and antibodies. Services include protein expression, antibodies generation, and recombinant antibodies production. Three different but complementary expression systems:E. coli(bacterial system), baculovirus in insect cells and mammalian cells are offered to meet customers specific requirements. Some of their protein products include Human FGF2 (fibroblast growth factor 2 recombinant protein), RAC-alpha serine/threonine-protein kinase recombinant protein 6xHis tagged, human ANXA2A2 recombinant protein) and other such proteins.